CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
NCT00893516 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2024-04-09
Summary
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Conditions
Interventions
- BIOLOGICAL
-
CHOP + CD4
- DRUG
-
CHOP
Sponsors & Collaborators
-
Emergent BioSolutions
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2008-10-31
- Completion
- 2008-12-31
More Related Trials
-
A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma
NCT01355783 ·Status: WITHDRAWN ·Phase: PHASE3
-
AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
NCT05678933 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma
NCT00169156 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT04922567 ·Status: RECRUITING ·Phase: PHASE2
-
Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
NCT05572983 ·Status: RECRUITING ·Phase: PHASE2
-
Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
NCT00725231 ·Status: UNKNOWN ·Phase: PHASE3
-
EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas
NCT07339527 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma
NCT06173999 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
NCT06947967 ·Status: RECRUITING ·Phase: PHASE3
-
RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas
NCT01198665 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma
NCT06963632 ·Status: NOT_YET_RECRUITING
-
Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
NCT00004039 ·Status: WITHDRAWN ·Phase: PHASE2
-
CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma
NCT03542266 ·Status: COMPLETED ·Phase: PHASE2
-
Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients
NCT03318835 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
NCT00992992 ·Status: COMPLETED ·Phase: PHASE2
-
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
NCT01746992 ·Status: UNKNOWN ·Phase: PHASE4
-
Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies
NCT00072514 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
NCT03631862 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)
NCT01553786 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL
NCT05138458 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma
NCT00003150 ·Status: COMPLETED ·Phase: PHASE3
-
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
NCT00006721 ·Status: COMPLETED ·Phase: PHASE3
-
HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
NCT00877656 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
NCT00177554 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)
NCT00930605 ·Status: COMPLETED ·Phase: PHASE2